» Articles » PMID: 30821815

P. Aeruginosa Flow-cell Biofilms Are Enhanced by Repeated Phage Treatments but Can Be Eradicated by Phage-ciprofloxacin Combination

Overview
Journal Pathog Dis
Date 2019 Mar 2
PMID 30821815
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Phage therapy has shown promising results in the treatment of Pseudomonas aeruginosa biofilm infections in animal studies and case reports. The aim of this study was to quantify effects of phage treatments on P. aeruginosa biofilm production and structure. Confocal scanning microscopy was used to follow the interaction between a cocktail of three virulent phages and P. aeruginosa flow-cell biofilms. The role of (i) biofilm age, (ii) repeated phage treatments, (iii) alginate production and (iv) the combination with sub-MIC levels of ciprofloxacin was investigated. Single phage treatment in the early biofilm stages significantly reduced P. aeruginosa PAO1 biovolume (85%-98% reduction). Repeated phage treatments increased the biovolume from 18.25 (untreated biofilm) to 22.24 and 31.07 µm3/µm2 for biofilms treated with phages twice and thrice, respectively. Alginate protected against the phage treatment as the live biovolume remained unaffected by the phage treatment in the mucoid biofilm (20.11 µm3/µm2 in untreated and 21.74 µm3/µm2 in phage-treated biofilm) but decreased in the PAO1 biofilm from 27.35 to 0.89 µm3/µm2. We show that the combination of phages with antibiotics at sub-MIC levels caused a ∼6 log units reduction in the abundance of P. aeruginosa cells in biofilms and that phage treatment increased the size of microcolonies in flow-cell system.

Citing Articles

The landscape of biofilm models for phage therapy: mimicking biofilms in diabetic foot ulcers using 3D models.

Martinet M, Thomas M, Bojunga J, Pletz M, Vehreschild M, Wurstle S Front Microbiol. 2025; 16:1553979.

PMID: 40066272 PMC: 11891221. DOI: 10.3389/fmicb.2025.1553979.


Successful Treatment of a Patient With Chronic Bronchiectasis Using an Induced Native Phage Cocktail: A Case Report.

Jernigan D, Hentish R Cureus. 2025; 17(1):e77681.

PMID: 39834667 PMC: 11744022. DOI: 10.7759/cureus.77681.


Cystic fibrosis and the clinical biofilm revolution A survey of the Danish CF Center's contribution.

Hoiby N Biofilm. 2025; 9():100246.

PMID: 39811797 PMC: 11732244. DOI: 10.1016/j.bioflm.2024.100246.


in the Frontline of the Greatest Challenge of Biofilm Infection-Its Tolerance to Antibiotics.

Hoiby N, Moser C, Ciofu O Microorganisms. 2024; 12(11).

PMID: 39597505 PMC: 11596597. DOI: 10.3390/microorganisms12112115.


The synergistic effect between phages and Ceftolozane/Tazobactam in endotracheal tube biofilm.

Oliveira V, Soler-Comas A, Rocha A, Silva-Lovato C, Watanabe E, Torres A Emerg Microbes Infect. 2024; 13(1):2420737.

PMID: 39530158 PMC: 11571741. DOI: 10.1080/22221751.2024.2420737.